Insulin resistance status and four-year changes in other cardiometabolic risk factors in West-African adults: the Benin study

Abstract

Background:

The association of insulin resistance (IR) with other cardiometabolic risk (CMR) factors in sub-Saharan Africans is poorly documented. This study examined the links between IR and the evolution of blood pressure (BP), glycaemia, serum lipids and abdominal obesity in the population of Benin.

Design:

Population-based longitudinal study.

Methods:

This study initially included 541 apparently healthy Beninese adults (50% women) aged 25–60 years who were randomly selected in a large city, a small town and a rural area. After a baseline survey, our subjects were followed up after 2 years, and again at 4 years. IR based on homeostasis model assessment (HOMA), blood glucose, BP, waist circumference (WC), triglycerides, total cholesterol and HDL-cholesterol were measured. Complete data at the end of the follow-up periods was available for 416 subjects.

Results:

IR was more prevalent in women than in men (33.2% versus 17.8%) and it was generally associated with more adverse values of CMR factors, excepting BP. In controlling for baseline age, sex, WC, diet, lifestyle variables and WC changes; the relative risk (RR) of hyperglycemia over 4 years was as least 3-fold in IR subjects, compared to normal subjects. The RR of abdominal obesity was 5.3 (1.04–26.93) in IR women, compared to non-IR. The association of IR with the evolution of dyslipidemia was inconsistent, but IR tended to exacerbate low HDL-cholesterol.

Conclusion:

Over 4 years, IR exacerbated hyperglycemia in both men and women, and abdominal obesity in women, but IR did not affect blood pressure. Further research on the link found between IR and dyslipidemia, particularly low HDL-C, is needed in sub-Saharan Africa.

Keywords

Abdominal fat Benin blood glucose blood pressure cardiometabolic risk factors dyslipidemia epidemiology hyperglycemia insulin resistance sub-Saharan Africa

Get full access to this article

View all access options for this article.

References

Bonora

Kiechl

Willeit

. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: The Bruneck study. Diabetes Care 2007; 30: 318–324.

Luke JN, Brown AD, Brazionis L, et al. Exploring clinical predictors of cardiovascular disease in a Central Australian aboriginal cohort. Eur J Prev Cardiolog 2012 Epub ahead of print 24 January 2012. DOI: 10.1177/2047487312437713.

World Health Organization. Diabetes. Fact sheet N°312. 2011.

World Health Organization. Cardiovascular diseases. Fact sheet N° 17. 2011.

Lindholm

Mendis

. Prevention of cardiovascular disease in developing countries. The Lancet 2007; 370: 720–722.

Wen

Chan

Tsai

. Attributable mortality burden of metabolic syndrome: Comparison with its individual components. Eur J Cardiovasc Prev Rehabil 2011; 18: 561–573.

Delisle

Ntandou-Bouzitou

Agueh

. Urbanisation, nutrition transition and cardiometabolic risk: The Benin study. Br J Nutr 2011; 107: 1534–1544.

Sodjinou

Agueh

Fayomi

. Obesity and cardio-metabolic risk factors in urban adults of Benin: Relationship with socio-economic status, urbanisation, and lifestyle patterns. BMC Pub Health 2008; 8: 1–13.

Ntandou

Delisle

Agueh

. Abdominal obesity explains the positive rural-urban gradient in the prevalence of the metabolic syndrome in Benin, West Africa. Nutr Res 2009; 29: 180–189.

10.

Sossa C, Delisle H, Agueh A, et al. Four-year trends in cardiometabolic risk factors according to baseline abdominal obesity status in West-African adults: The Benin Study J Obes 2012; 740854.

11.

Gaillard

Schuster

Osei

. Metabolic syndrome in Black people of the African diaspora: The paradox of current classification, definition and criteria. Ethn Dis 2009; 19: 1–7.

12.

Alberti

Eckel

Grundy

. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640–1645.

13.

Millan

Pinto

Munoz

. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag 2009; 5: 757–765.

14.

IBL International. Insulin ELISA: Instructions for use. Hamburg, IBL International, 2011.

15.

Matthews

Hosker

Rudenski

. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.

16.

WHO/FAO. Vitamin and mineral requirements in human nutrition. 2nd ed. Geneva: World Health Organization, 2005.

17.

WHO. WHO STEPS instrument question-by-question. Geneva: World Health Organization, 2009.

18.

Motala

Esterhuizen

Pirie

. The prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South African community. Diab Care 2011; 34: 1032–1037.

19.

Osei

Schuster

. Effects of race and ethnicity on insulin sensitivity, blood pressure, and heart rate in three ethnic populations: Comparative studies in African-Americans, African immigrants (Ghanaians), and White Americans using ambulatory blood pressure monitoring. Am J Hypertens 1996; 9: 1157–1164.

20.

Kidambi

Kotchen

Krishnaswami

. Hypertension, insulin resistance, and aldosterone: Sex-specific relationships. J Clin Hypertens 2009; 11: 130–137.

21.

Reaven

. Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: Similarities and differences. J Clin Hypertens 2011; 13: 238–243.

22.

Despres

Couillard

Gagnon

. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: The health, risk factors, exercise training, and genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol 2000; 20: 1932–1938.

23.

Ginsberg

. Insulin resistance and cardiovascular disease. J Clin Invest 2000; 106: 453–458.

24.

McLaughlin

Abbasi

Cheal

. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003; 139: 802–809.

25.

Sumner

Vega

Genovese

. Normal triglyceride levels despite insulin resistance in African Americans: Role of lipoprotein lipase. Metabolism 2005; 54: 902–909.

26.

Sumner

Cowie

. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008; 196: 696–703.

27.

Ford

Meng

. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc Diabetol 2008; 7: 1–9.

28.

Bovet

Faeh

Gabriel

. The prediction of insulin resistance with serum triglyceride and high-density lipoprotein cholesterol levels in an East African population. Arch Intern Med 2006; 166: 1236–1237.

29.

Sumner

Zhou

Doumatey

. Low HDL-cholesterol with normal triglyceride levels is the most common lipid pattern in West Africans and African Americans with metabolic syndrome: Implications for cardiovascular disease prevention. CVD Prev Control 2010; 5: 75–80.

30.

Arslanian

Suprasongsin

. Differences in the in vivo insulin secretion and sensitivity of healthy Black versus White adolescents. J Pediatrics 1996; 129: 440–443.

31.

Després

Arsenault

Cote

. Abdominal obesity: The cholesterol of the 21st century? Can J Cardiol 2008; 24(Suppl D): 7D–12D.